Clinical Trial Update: Newly-diagnosed Pediatric Ph-positive B-ALL Protocol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial protocol for newly diagnosed Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia, currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), Childhood Leukemia, Acute Lymphoblastic | Phase 3 | Status: RECRUITING